Pasar al contenido principal

SEÑALIZACION POR LA QUINASA HUMANA VRK1 EN LA PATOGENESIS DEL CANCER Y LA NEURODEGENERACION

SAF2013-44810-R

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2013
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Secretaría de Estado de Educación, Formación Profesional y Universidades
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

VRK1 chromatin kinase phosphorylates H2AX and is required for foci formation induced by DNA damage

  • Salzano, Marcella
  • Sanz-García, Marta
  • Monsalve, Diana M.
  • Moura, David S.
  • Lazo, Pedro A.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License., All types of DNA damage cause a local alteration and relaxation of chromatin structure. Sensing and reacting to this initial chromatin alteration is a necessary trigger for any type of DNA damage response (DDR). In this context, chromatin kinases are likely candidates to participate in detection and reaction to a locally altered chromatin as a consequence of DNA damage and, thus, initiate the appropriate cellular response. In this work, we demonstrate that VRK1 is a nucleosomal chromatin kinase and that its depletion causes loss of histones H3 and H4 acetylation, which are required for chromatin relaxation, both in basal conditions and after DNA damage, independently of ATM. Moreover, VRK1 directly and stably interacts with histones H2AX and H3 in basal conditions. In response to DNA damage induced by ionizing radiation, histone H2AX is phosphorylated in Ser139 by VRK1. The phosphorylation of H2AX and the formation of gH2AX foci induced by ionizing radiation (IR), are prevented by VRK1 depletion and are rescued by kinase-active, but not kinase-dead, VRK1. In conclusion, we found that VRK1 is a novel chromatin component that reacts to its alterations and participates very early in DDR, functioning by itself or in cooperation with ATM., DMM and M S-G were supported by JAE-CSIC-Fondo Social Europeo fellowships. DSM was supported by a Ministerio de Ciencia e Innovación-FPI predoctoral fellowship. This work was funded by grants from Ministerio de Econom ıa y Competitividad (SAF2010-14935, SAF2013-44810R, SAF2014-57791-REDC) and Consejerıa de Educacion de la Junta de Castilla y Leon (CSI002U14) to PAL., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

VRK1 regulates Cajal body dynamics and protects coilin from proteasomal degradation in cell cycle

  • Cantarero, Lara
  • Sanz-García, Marta
  • Vinograd-Byk, Hadar
  • Renbaum, Paul
  • Levy-Lahad, Ephrat
  • Lazo, Pedro A.
Cajal bodies (CBs) are nuclear organelles associated with ribonucleoprotein functions and RNA maturation. CBs are assembled on coilin, its main scaffold protein, in a cell cycle dependent manner. The Ser-Thr VRK1 (vaccinia-related kinase 1) kinase, whose activity is also cell cycle regulated, interacts with and phosphorylates coilin regulating assembly of CBs. Coilin phosphorylation is not necessary for its interaction with VRK1, but it occurs in mitosis and regulates coilin stability. Knockdown of VRK1 or VRK1 inactivation by serum deprivation causes a loss of coilin phosphorylation in Ser184 and of CBs formation, which are rescued with an active VRK1, but not by kinase-dead VRK1. The phosphorylation of coilin in Ser184 occurs during mitosis before assembly of CBs. Loss of coilin phosphorylation results in disintegration of CBs, and of coilin degradation that is prevented by proteasome inhibitors. After depletion of VRK1, coilin is ubiquitinated in nuclei, which is partly mediated by mdm2, but its proteasomal degradation occurs in cytosol and is prevented by blocking its nuclear export. We conclude that VRK1 is a novel regulator of CBs dynamics and stability in cell cycle by protecting coilin from ubiquitination and degradation in the proteasome, and propose a model of CB dynamics., L. C. and M. S-G. were funded by JAE-CSIC-Fondo Social Europeo fellowships. This work was supported by grants from Ministerio de Ciencia e Innovación (SAF2010-14935), Ministerio de Economía y Competitividad (SAF2013-44810R, SAF2014-57791-REDC), and Junta de Castilla y León-Consejería de Educación (CSI002U14) to P.A.L;and grant (702/13) from the Israel Science Foundation to P.R. and E.L.L., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

VRK1 phosphorylates and protects NBS1 from ubiquitination and proteasomal degradation in response to DNA damage

  • Monsalve, Diana M.
  • Campillo-Marcos, Ignacio
  • Salzano, Marcella
  • Sanz-García, Marta
  • Cantarero, Lara
  • Lazo, Pedro A.
Under a Creative Commons license., NBS1 is an early component in DNA-Damage Response (DDR) that participates in the initiation of the responses aiming to repair double-strand breaks caused by different mechanisms. Early steps in DDR have to react to local alterations in chromatin that are induced by DNA damage. NBS1 participates in the early detection of DNA damage and functions as a platform for the recruitment and assembly of components that are sequentially required for the repair process. In this work we have studied whether the VRK1 chromatin kinase can affect the activation of NBS1 in response to DNA damage induced by ionizing radiation. VRK1 is forming a basal preassembled complex with NBS1 in non-damaged cells. Knockdown of VRK1 resulted in the loss of NBS1 foci induced by ionizing radiation, an effect that was also detected in cell-cycle arrested cells and in ATM (−/−) cells. The phosphorylation of NBS1 in Ser343 by VRK1 is induced by either doxorubicin or IR in ATM (−/−) cells. Phosphorylated NBS1 is also complexed with VRK1. NBS1 phosphorylation by VRK1 cooperates with ATM. This phosphorylation of NBS1 by VRK1 contributes to the stability of NBS1 in ATM (−/−) cells, and the consequence of its loss can be prevented by treatment with the MG132 proteasome inhibitor of RNF8. We conclude that VRK1 regulation of NBS1 contributes to the stability of the repair complex and permits the sequential steps in DDR., D.M.M, M. S-G and L. C. were supported by JAE-CSIC-Fondo Social Europeo fellowships. I. C-M. was supported by Ministerio de Economía y Competitividad-FPI-Fondo Social Europeo fellowship. This work was funded by grants from Ministerio de Economía y Competitividad (SAF2013-44810R; SAF2014-57791-REDC) and Consejería de Educación de la Junta de Castilla y León (CSI002U14 and UIC-017) to P.A.L., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Oncogenic Sox2 regulates and cooperates with VRK1 in cell cycle progression and differentiation

  • Moura, David S.
  • Fernández, Isabel F.
  • Marín-Royo, Gema
  • López-Sánchez, Inmaculada
  • Martín-Doncel, Elena
  • Vega, Francisco M.
  • Lazo, Pedro A.
Sox2 is a pluripotency transcription factor that as an oncogene can also regulate cell proliferation. Therefore, genes implicated in several different aspects of cell proliferation, such as the VRK1 chromatin-kinase, are candidates to be targets of Sox2. Sox 2 and VRK1 colocalize in nuclei of proliferating cells forming a stable complex. Sox2 knockdown abrogates VRK1 gene expression. Depletion of either Sox2 or VRK1 caused a reduction of cell proliferation. Sox2 up-regulates VRK1 expression and both proteins cooperate in the activation of CCND1. The accumulation of VRK1 protein downregulates SOX2 expression and both proteins are lost in terminally differentiated cells. Induction of neural differentiation with retinoic acid resulted in downregulation of Sox2 and VRK1 that inversely correlated with the expression of differentiation markers such as N-cadherin, Pax6, mH2A1.2 and mH2A2. Differentiation-associated macro histones mH2A1.2and mH2A2 inhibit CCND1 and VRK1 expression and also block the activation of the VRK1 promoter by Sox2. VRK1 is a downstream target of Sox2 and both form an autoregulatory loop in epithelial cell differentiation., DSM and IL-S were supported by MINECO-FPI predoctoral fellowships. IFF was supported by JAE-CSIC-Fondo Social Europeo predoctoral fellowship. EM-D was supported by JCyL-Consejería de Educación-Fondo Social Europeo predoctoral fellowship. This work was funded by grants from Ministerio de Economía y Competitividad (SAF2013-44810R, SAF2014-57791-REDC) and Consejería de Educación de la Junta de Castilla y León (CSI002U14 and UIC-017) to P.A.L., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The spinal muscular atrophy with pontocerebellar hypoplasia gene VRK1 regulates neuronal migration through an amyloid-β precursor protein-dependent mechanism

  • Vinograd-Byk, Hadar
  • Cantarero, Lara
  • Lazo, Pedro A.
  • Renbaum, Paul
  • Levy-Lahad, Ephrat
Spinal muscular atrophy with pontocerebellar hypoplasia (SMA-PCH) is an infantile SMA variant with additional manifestations, particularly severe microcephaly. We previously identified a nonsense mutation in Vaccinia-related kinase 1 (VRK1), R358X, as a cause of SMA-PCH. VRK1-R358X is a rare founder mutation in Ashkenazi Jews, and additional mutations in patients of different origins have recently been identified.VRK1is a nuclear serine/threonine protein kinaseknownto play multiple roles in cellular proliferation, cell cycle regulation, and carcinogenesis. However, VRK1 was not known to have neuronal functions before its identification as a gene mutated in SMA-PCH. Here we show that VRK1-R358X homozygosity results in lack of VRK1 protein, and demonstrate a role for VRK1 in neuronal migration and neuronal stem cell proliferation. Using shRNA in utero electroporation in mice, we show that Vrk1 knockdown significantly impairs cortical neuronal migration, and affects the cell cycle of neuronal progenitors. Expression of wild-type human VRK1 rescues both proliferation and migration phenotypes. However, kinase-dead human VRK1 rescues only the migration impairment, suggesting the role of VRK1 in neuronal migration is partly noncatalytic. Furthermore, we found that VRK1 deficiency in human and mouse leads to downregulation of amyloid-β precursor protein (APP), a known neuronal migration gene. APP overexpression rescues the phenotype caused by Vrk1 knockdown, suggesting that VRK1 affects neuronal migration through an APP-dependent mechanism., This study was supported by grants from the Israel Science Foundation (Grant 702/13 to P.R. and E.L.-L., and Grant 47/10 and 322/13 to O.R. and T.S.); by the Minerva Foundation with funding from the Federal German Ministry for Education and Research, the Jérôme Lejeune Foundation, the Benoziyo Center for Neurological diseases, the Kekst Family Center for Medical Genetics, and the David and Fela Shapell Family Center for Genetic Disorders Research (to O.R.); by the JAE (Programa Junta para la Amplición de Estudios) Consejo Superior de Investigaciones Científicas Fondo Social Europeo fellowship (to L.C.); by the Ministerio de Educación, Ciencia e Innovación (SAF2010-14935 and SAF2013-44810R, to P.A.L.); and by Kutxa-Fundación Inbiomed (to P.A.L.)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Tesis doctoral (DoctoralThesis)

Implicación de la quinasa humana VRK1 en la formación de los cuerpos de Cajal y sus implicaciones patológicas

  • Cantarero, Lara
Memoria presentada por la licenciada en biología Lara Cantarero Abad para optar al grado de doctor por la Universidad de Salamanca, y realizada en el Instituto de Biología Molecular y Celular del Cáncer., Las atrofias musculares espinales (AME) y ataxias son un grupo de enfermedades neurodegenerativas que causan la muerte a edades muy tempranas. Numerosos genes están implicados en dichas patologías, siendo su mecanismo de acción a nivel molecular aún desconocido. La mutación mejor caracterizada y causante de la AME de tipo I es la del gen SMN1 (survival motor neuron 1). SMN es una proteína que se localiza en el citosol, formando parte del complejo SMN, y que se acumula en los Cuerpos de Cajal (CBs) interaccionando con la Coilina. La Coilina es la proteína marcadora de los CBs y es regulada por fosforilación (se han descrito al menos 11 residuos fosforilables) y metilación. Recientemente se han identificado cuatro mutaciones en la quinasa humana VRK1 (R358X,R89Q, R133C y V236M) causantes de hipoplasia pontocerebelosa de tipo 1 y patologías sensoriomotoras hereditarias que cursan con ataxia y debilidad musculares y acaban provocando la muerte a edades muy tempranas. La mutación mejor caracterizada es la R358X, que codifica para una proteína truncada, deslocalizándose del núcleo debido a la pérdida de su región C-terminal. Además, se ha descrito como VRK1 interacciona y fosforila a la Coilina en el residuo serina 184. En este trabajo de tesis doctoral mostramos como la fosforilación de la Coilina por la quinasa humana VRK1 es crucial para la correcta formación de los Cuerpos de Cajal; el silenciamiento de dicha quinasa produce la desintegración y desaparición de estos suborgánulos nucleares. Este efecto es debido, en un primer momento, a la desoligomerización de la coilina, que deja de estar presente en complejos de alto peso molecular. Posteriormente, hemos descrito como la coilina se ubiquitina, a través de la ubiquitina ligasa Mdm2, en el núcleo, para posteriormente ser exportada al citosol donde se degradará en el proteasoma. Este dato es importante debido a que se ha detectado una posible señal de exporte nuclear por primera vez en esta proteína. Además, el silenciamiento de VRK1, provoca una salida masiva de SMN al citosol debido al desensamblaje de los CBs. Esta salida se recupera al inhibir el exporte nuclear con leptomicina B. Adicionalmente, hemos visto que la quinasa VRK1 regula transcripcionalmente a SMN, por algún mecanismo aún desconocido. Sin embargo, no afecta a la inetracción entre SMN y el factor de transcripción p53 o a la estabilidad de SMN. Finalmente, en este trabajo hemos estudiado y caracterizado a todos los mutantes de VRK1 causantes de patologías neurodegenerativas. Hemos visto que el mutante R89Q presenta una mayor actividad quinasa, reflejada en una mayor autofosforilación y fosforilación de sustratos conocidos como p53 o coilina. Sin embargo, los mutantes R133C y R358X, son prácticamente igual de inactivos a la quinasa inactiva K179E, de forma que no tienen capacidad de autofosforilarse ni de fosforilar sustratos. Por último, el mutante V236M, es igual de activo a la quinasa silvestre. Además, este grado de actividad de los distintos mutantes se refleja también en su estabilidad, de tal forma que los más activos son más estables, mientras que las mutaciones que generan quinasas más inactivas son también más inestables. Cabe destacar que todos los mutantes interaccionan tanto con la Coilina como con SMN de igual manera. Así, estudios previos describen a VRK1 como una proteína importante en cáncer; ahora se nos presenta con un nuevo papel implicándose en patologías neurodegenerativas, siendo quizás importante su interacción con otras proteínas y sus posibles efectos., Esta memoria ha sido realizada siendo LARA CANTARERO ABAD beneficiaria de una beca pre-doctoral JAE-Fondo Social Europeo del Consejo Superior de Investigaciones Científicas (CSIC) para la realización de la tesis doctoral (2011-2015). La investigación en el laboratorio ha sido financiada por los siguientes proyectos: Ministerio de Educación y Ciencia, CONSOLIDER-INGENIO2010 (CSD- 007-0017); Ministerio de Ciencia e Innovación (SAF2010-14935); Junta de Castilla y León, Consejería de Educación (CSI006A11-2); CSIC-Hebrew University of Jerusalem, Shaare-Zedek Medical Center, Israel (Ref: PA1003032); Ministerio de Economía y Competitividad (SAF2013-44810R); Ministerio de Economía y Competitividad (SAF2014-57791-REDC); Junta de Castilla y León, Consejería de Educación (CSI002U14)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Reverting p53 activation after recovery of cellular stress to resume with cell cycle progression

  • Lazo, Pedro A.
The activation of p53 in response to different types of cellular stress induces several protective reactions including cell cycle arrest, senescence or cell death. These protective effects are a consequence of the activation of p53 by specific phosphorylation performed by several kinases. The reversion of the cell cycle arrest, induced by p53, is a consequence of the phosphorylated and activated p53, which triggers its own downregulation and that of its positive regulators. The different down-regulatory processes have a sequential and temporal order of events. The mechanisms implicated in p53 down-regulation include phosphatases, deacetylases, and protein degradation by the proteasome or autophagy, which also affect different p53 protein targets and functions. The necessary first step is the dephosphorylation of p53 to make it available for interaction with mdm2 ubiquitin-ligase, which requires the activation of phosphatases targeting both p53 and p53-activating kinases. In addition, deacetylation of p53 is required to make lysine residues accessible to ubiquitin ligases. The combined action of these downregulatory mechanisms brings p53 protein back to its basal levels, and cell cycle progression can resume if cells have overcome the stress or damage situation. The specific targeting of these down-regulatory mechanisms can be exploited for therapeutic purposes in cancers harbouring wild-type p53., The laboratory was supported by grants from Ministerio de Economía y Competitividad (SAF2013-44810-R), Agencia Estatal de Investigación (SAF2016-75744-R) and Consejería de Educación de la Junta de Castilla y León (CSI001U16)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Is centrosomal protein 70, a centrosomal protein with new roles in breast cancer dissemination and metastasis, a facilitator of epithelial-mesenchymal transition?

  • Lazo, Pedro A.
This commentary highlights the article by Shi et al that identified centrosomal protein 70 as a key mediator of breast cancer growth and metastasis., Supported by Ministerio de Economía y Competitividad Agencia Estatal de Investigación grants SAF2013-44810-R and SAF2016-75744-R., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Tesis doctoral (DoctoralThesis)

Roles of human VRK1 Ser-Thr kinase in the regulation of cell proliferation

  • Moura, David S.
Tesis Doctoral presentada por David da Silva Moura, elaborada en el Programa de Doctorado Biociencias: Biología y Clínica del Cáncer y Medicina Traslacional, y realizada en el Instituto de Biología Molecular y Celular del Cáncer de Salamanca (CSIC-USAL)., Cell proliferation and cell differentiation are different mechanisms occurring at different times of the cell life. However, the regulation of the switch from proliferation to differentiation and the role and fate of proliferation-related proteins are mostly unknown. Cell division is a high-regulated mechanism, involving several kinases, namely Vaccinia-related kinase 1 (VRK1) and Aurora kinase B (AurKB). These kinases assure the correct transmission of genetic information to the newly-formed cells, DNA replication, chromosome segregation and chromatin condensation. VRK1 is the first member of the VRK family and is ubiquitously expressed in all the tissues, especially high-proliferative tissue, including liver and thymus or cancer cells. Therefore, based on VRK1 features and expression, its role has been mostly related to the regulation of cell proliferation, including the regulation of transcription factors involved in cell cycle progression and DNA damage repair pathways, modulation of p53 levels, nuclear envelope assembly, Cajal body (CB) formation and maintenance, and fragmentation of the Golgi apparatus. Apart from these, VRK1 also contributes to the mitotic chromatin condensation through histone H3 phosphorylation, mainly, in the Thr3 residue (H3T3ph). H3T3ph is especially important for the formation, localization and function of the chromosomal passenger complex (CPC) on the centromeres, during mitosis. (see group publications). In turn, AurKB is a member of the aurora kinase family, alongside with AurKA and AurKC. The activity of this family of kinases is fulfilled during mitosis, and therefore, they are mitotic kinases critical for the mitotic regulation of centromere function, chromatin condensation, spindle assembly, chromosome alignment and segregation and, cytokinesis. AurKB is a component of CPC, along with Survivin, Borealin and INCENP and contributes to chromatin condensation, through H3S10 phosphorylation. On the other hand, the transcriptional factor (TF) Sox2, a member of the SRY-related HMG-box family of TFs is a master regulator of pluripotency, proliferation, survival and differentiation of embryonic stem cell (ESC)., Moreover, Yamanaka’s factor Sox2 is a cancer initiating cell biomarker in poorly differentiated or undifferentiated cancers, since these types of cancers have been characterized by many phenotypic traits similar to undifferentiated embryonic stem cells. Indeed, Sox2 is overexpressed in numerous tumors like breast cancer and lung cancer or in cancer cell lines suggesting the enormous oncogenic potential of this TF. It is also important to notice, that Sox2 combines with Oct4 to control cell cycle, through cyclin D1 promoter activation. Finally, also macro-histone H2A (macroH2A) can regulate cell differentiation and cell proliferation. Macro H2A (macroH2A1.1, macroH21.2 and macroH2A2) are histones variant that can replace conventional histone H2A in the nucleosomes, repressing cell proliferation genes and favoring cell differentiation genes. These histone variants change the chromatin conformation, affecting TFs binding and creating de novo activation and repression binding sites. It was also reported that macroH2A variants could regulate VRK1 levels. Initially, we observe that VRK1 is a chromatin kinase, besides its usual nucleo-plasmatic and cytoplasmatic localization, and interacts with the histone H3 by immuprecipitation (IP) and ‘’Pull-down’’ assays in early mitosis. Moreover, VRK1 phosphorylates directly the mitotic H3T3, as observed by kinase assay with cold ATP and phospho-specific antibodies. Next and focusing on VRK1 and AurKB relationship we observed that VRK1 and AurKb inhibits the kinase activity of one another, as observed by kinase assay with radiolabeled ATP. Moreover, increasing doses of VRK1, active or inactive, affected negatively the phosphorylation of AurKB-specific residue S10 on histone H3 in kinase assay with cold ATP. Besides, also increasing doses of AurKB, active and inactive, affected negatively the phosphorylation of H3T3 and the phosphorylation of p53T18 by VRK1. This effect is consequence of the formation of a stable complex between the two protein kinases and independent of any type of phosphorylation of one kinase on another. By IP and ‘’Pull-down’’ assay we observed that transfected VRK1 and transfected AurKB interact, forming a stable complex independent of VRK1 activity. VRK1 interacts with AurKB through both amino and carboxy terminals. The interaction between endogenous VRK1 and AurKB occurs in early mitosis, after cell arrest with nocodazole. Yet, no co-localization between the two kinases was, observed by immunofluorescence (IF). Moreover, VRK1 downregulation affected the localization of AurKB in early mitosis in IF assays. VRK1 downregulation avoids centromeric accumulation of AurKB, leading to a more diffuse distribution on the chromatin. This result is due to the loss of H3T3 phosphorylation, as observed by IF and western blot (WB). Loss of VRK1-dependent H3T3 phosphorylation affects the interaction of AurKB with Histone H3 in IP assays. Regarding VRK1 and reprogramming factors, VRK1 and Sox2 distribution was analyzed by immunohistochemistry on a stratified squamous epithelium and it was observed that Sox2 and VRK1 co-localize in the undifferentiated layers of the epithelium. The same result was observed by IF in several cell lines, such as NTera-2 (NT2), MCF-7 or MDA-MB-231. Moreover, VRK1 and Sox2 interact in IP assay. The interaction occurs between transfected proteins and between endogenous proteins, and it is through both VRK1 amino and carboxy terminals. Sox2 is a phosphorylation target of VRK1 as determined by kinase assay with radiolabelled ATP. Sox2, as a regulator of cell proliferation regulates proliferative genes, including VRK1. SOX2 regulates VRK1 promoter in luciferase assays, increasing, when overexpressed, the RNA and protein levels of the kinase, as observed by qRT-PCR, WB and IF. The result was observed in NT2, MDA-MB-231 and MCF-7 cell line. In turn, VRK1 downregulation increases RNA (qRT-PCR) and protein levels (IF and WB) of Sox2 in NT2, MDA-MB-231 and MCF-7, creating a feedback loop between VRK1 and Sox2. The overexpression of VRK1 produced the opposite result. Furthermore, VRK1 and Sox2 cooperate in the activation of CCND1 gene, in luciferase assays potentiating proliferation. After induction of cell differentiation with retinoic acid, both Sox2 and VRK1 RNA and protein are downregulated and they are absent or significantly down-regulated in terminally differentiated epithelial cells. In terminally differentiated cells, macroH2A variants 1.2 and 2 repress VRK1 and CCND1 gene promoter, as determined by luciferase assay. In conclusion, VRK1 participates in the regulation of cell proliferation, through two new and independent mechanisms. One by actively regulating AurKB and the other by regulating the balance between cell proliferation and cell differentiation., Esta memoria ha sido realizada siendo David da Silva Moura beneficiario de una beca predoctoral Formación de Personal Investigador (FPI; referencia BES2011-046945) del Ministerio de Economía y Competitividad para la realización de la tesis doctoral (2011-2015). La investigación en el laboratorio ha sido financiada por los siguientes proyectos: Ministerio de Educación y Ciencia. CONSOLIDER-INGENIO2010 (CDS-007-0017). Ministerio de Ciencia e Innovación: (SAF2010-14935). Junta de Castilla y León, Consejería de Educación: (CSI006A11-2) - (CSI002U14). Ministerio de Economía y Competitividad: (SAF2013-44810R) - (SAF2014-57791-REDC)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

VRK1 and AURKB form a complex that cross inhibit their kinase activity and the phosphorylation of histone H3 in the progression of mitosis

  • Moura, David S.
  • Campillo-Marcos, Ignacio
  • Vázquez-Cedeira, Marta
  • Lazo, Pedro A.
© The Author(s) 2018., Regulation of cell division requires the integration of signals implicated in chromatin reorganization and coordination of its sequential changes in mitosis. Vaccinia-related kinase 1 (VRK1) and Aurora B (AURKB) are two nuclear kinases involved in different steps of cell division. We have studied whether there is any functional connection between these two nuclear kinases, which phosphorylate histone H3 in Thr3 and Ser10, respectively. VRK1 and AURKB are able to form a stable protein complex, which represents only a minor subpopulation of each kinase within the cell and is detected following nocodazole release. Each kinase is able to inhibit the kinase activity of the other kinase, as well as inhibit their specific phosphorylation of histone H3. In locations where the two kinases interact, there is a different pattern of histone modifications, indicating that there is a local difference in chromatin during mitosis because of the local complexes formed by these kinases and their asymmetric intracellular distribution. Depletion of VRK1 downregulates the gene expression of BIRC5 (survivin) that recognizes H3-T3ph, both are dependent on the activity of VRK1, and is recovered with kinase active murine VRK1, but not with a kinase-dead protein. The H3–Thr3ph–survivin complex is required for AURB recruitment, and their loss prevents the localization of ACA and AURKB in centromeres. The cross inhibition of the kinases at the end of mitosis might facilitate the formation of daughter cells. A sequential role for VRK1, AURKB, and haspin in the progression of mitosis is proposed., This work was funded by grants from Ministerio de Economía y Competitividad (SAF2013-44810-R, SAF2014-57791-REDC), Agencia Estatal de Investigación (SAF2016-75744-R), and Consejería de Educación de la Junta de Castilla y León (CSI001U16 and UIC-17) to P.A.L.